Elevance Health Inc

ELV

Equity

ISIN null / Valor 26124340

New York Stock Exchange, Inc (2025-10-17)

USD 348.77+0.17%

Elevance Health Inc
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Elevance Health Inc is a healthcare company that provides remote exam kits to members in five affiliated health plans, enabling doctors to conduct thorough examinations during telehealth visits. The kits allow for listening to patients' heart and lung sounds, as well as examining their mouths and ears. The company's focus on enhancing telehealth services through innovative technology demonstrates its commitment to improving patient care and access to healthcare services.

Summarized from source with an LLMView SourceSector: Healthcare

Operating Revenue Growth

Elevance Health Inc's operating revenue for Q2 2025 reached $49.4 billion, marking a 14.3% increase from Q2 2024. This growth was driven by higher premium yields in the Health Benefits segment, recent acquisitions, and an expansion in Medicare Advantage membership, partially offset by a decline in Medicaid membership.

Earnings Per Share (EPS)

The company's diluted EPS for Q2 2025 was $7.72, with an adjusted diluted EPS of $8.84. Elevance Health has revised its full-year 2025 adjusted diluted EPS guidance upward to approximately $30.00, reflecting strong operational performance despite increased medical cost trends.

Shareholder Returns

Elevance Health Inc has returned $2.0 billion of capital to shareholders year-to-date through share repurchases and dividends. In Q2 2025, the company repurchased 0.9 million shares for $379 million and declared a quarterly dividend of $1.71 per share, totaling $385 million in distributions.

Segment Performance

The Health Benefits segment generated $41.6 billion in operating revenue, up 12% year-over-year, while the Carelon segment saw a significant increase of 36% to $18.1 billion. Both segments contributed to overall profitability, with operating gains of $1.6 billion and $0.9 billion respectively.

Summarized from source with an LLMView Source

Key figures

-21.5%1Y

-26.9%3Y

17.5%5Y

Performance

38.2%1Y

28.8%3Y

28.4%5Y

Volatility